ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Priority situations for use of directly observed therapy

Priority situations for use of directly observed therapy
Patients with the following conditions/circumstances:[1-6]
  • Positive sputum smears
  • Delayed culture conversion (sputum obtained at/after completion of intensive-phase therapy is culture positive)
  • Treatment failure
  • Relapse
  • Drug resistance
  • Homelessness
  • Current or prior substance abuse
  • Use of intermittent dosing
  • HIV infection
  • Previous nonadherence to therapy
  • Children and adolescents
  • Mental, emotional, or physical disability (ie, cognitive deficits such as dementia; neurological deficits; medically fragile patients; or patients with blindness or severe loss of vision)
  • Resident at correctional or long-term care facility
  • Previous treatment for active or latent tuberculosis
HIV: human immunodeficiency virus.
References:
  1. Centers for Disease Control and Prevention. Managing tuberculosis patients and improving adherence. CDC, Atlanta, GA 2014.
  2. Burman WJ, Cohn DL, Rietmeijer CA, et al. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 1997; 111:1168.
  3. Moonan PK, Quitugua TN, Pogoda JM, et al. Does directly observed therapy (DOT) reduce drug resistant tuberculosis? BMC Public Health 2011; 11:19.
  4. Kim S, Crittenden K. Treatment completion among TB patients returned to the community from a large urban jail. J Community Health 2007; 32:135.
  5. Ehman M, Shaw T, Cass A, et al. Developing and using performance measures based on surveillance data for program improvement in tuberculosis control. J Public Health Manag Pract 2013; 19:E29.
  6. Mitruka K, Winston CA, Navin TR. Predictors of failure in timely tuberculosis treatment completion, United States. Int J Tuberc Lung Dis 2012; 16:1075.
Reproduced from: Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 2016; 63(7):e147-e195, by permission of Oxford University Press on behalf of the Infectious Diseases Society of America. Copyright © 2016 Oxford University Press. Available at: www.idsociety.org.
Graphic 109545 Version 16.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟